U.S. market Closed. Opens in 14 minutes

CPRX | Catalyst Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
Revenue398.20M214.20M140.83M119.07M102.31M500.00KN/AN/AN/AN/AN/AN/AN/A488.96KN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue84.53M34.39M21.88M17.04M14.76M19.92M45.69K43.41K34.47KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit313.67M179.81M118.95M102.03M87.55M-19.42M-45.69K-43.41K-34.47KN/AN/AN/AN/A488.96KN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses259.43M77.97M66.56M60.73M55.72M35.80M18.68M19.28M20.40M14.59M10.31M5.22M6.08M4.51M7.28M10.89M5.03M2.90M1.82M542.96K-428.62K255.94K
Selling, General & Admin133.71M58.18M49.63M44.23M36.88M15.88M7.30M7.91M8.60M4.47M2.21M2.56M2.70M2.21M2.18M2.18M2.04M1.91M359.28K164.70KN/AN/A
Research & Development93.15M19.79M16.94M16.50M18.84M19.92M11.38M11.37M11.80M10.12M8.10M2.66M3.38M2.31M5.10M8.71M2.99M989.14K1.46M378.25KN/A137.68K
Other Operating ExpensesN/A2.88M282.00K586.90K1.59M1.29M454.16K321.61K100.39K76.23KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-428.62K118.27K
Operating Income86.81M101.84M52.38M41.30M31.82M-35.30M-18.68M-19.28M-20.40M-14.59M-10.31M-5.22M-6.08M-4.02M-7.28M-10.89M-5.03M-2.90M-1.82M-542.96K-428.62K-255.94K
Other Expenses / Income7.70M2.88M282.00K586.90K1.59M1.29M267.26K1.21M165.39K-917.63K-1.84M1.14M-308.92K17.86K33.47K329.35K887.64K172.87K16.79K3.14KN/AN/A
Before Tax Income94.51M104.72M52.67M41.89M33.41M-34.00M-18.41M-18.07M-20.23M-15.51M-12.15M-4.08M-6.39M-4.01M-7.24M-10.56M-4.14M-2.73M-1.81M-539.82KN/A-255.94K
Income Tax Expenses23.10M21.64M13.19M-33.09M1.53M2.58M141.22K-929.54K-99.47K993.87K1.84M-1.16M308.92KN/AN/AN/AN/AN/AN/AN/A428.62KN/A
Net Income71.41M83.08M39.48M74.98M31.88M-34.00M-18.41M-18.07M-20.23M-15.51M-12.15M-4.08M-6.39M-4.01M-7.24M-10.56M-4.14M-2.73M-1.81M-539.82K-428.62K-255.94K
Interest ExpensesN/AN/AN/AN/AN/A1.29M454.16K321.61K100.39K76.23K47.42K14.98K10.98K17.86K33.47K329.35KN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding106.28M103.37M103.38M103.51M102.94M102.63M85.80M82.88M80.86M64.14M45.45M30.03M21.73M18.58M15.07M13.01M12.53M7.69M6.20M2.92M2.92M2.36M
Diluted Shares Outstanding113.75M111.38M107.80M106.24M106.02M102.63M85.80M82.88M80.86M64.14M45.45M30.03M21.73M18.58M15.07M13.01M12.53M7.69M6.20M2.92M2.92M2.36M
EBITDA119.69M101.84M52.38M41.30M31.82M-35.26M-18.49M-18.03M-20.46M-13.57M-8.40M-6.35M-6.35M-4.00M-7.21M-10.53M-5.01M-2.72M-1.82M-542.59K-428.62K-255.94K
EBITDA Margin30.06%47.54%37.20%34.69%31.11%-7,051.44%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-817.75%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT94.51M104.72M52.67M41.89M33.41M-30.13M-17.82M-18.68M-20.23M-14.44M-10.26M-5.22M-6.07M-3.99M-7.21M-10.24M-4.14M-2.73M-1.81M-539.82KN/A-255.94K
EBIT Margin23.73%48.89%37.40%35.18%32.66%-6,025.71%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-815.71%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙